We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Kempex

Back to Our investments

About Kempex

Activity: Wholesaler and manufacturer of (pharmaceutical) raw materials for the animal feed industry
Headquarters: Volkel
Sector: Wholesale
Transaction type: Pre-exit
Strategy: Autonomous growth
Investment year: 2013
Year of establishment: 1987
Website: www.kempex.net
Kempex

About Kempex

Established in 1987, Kempex stands as an respected international trading company, specialising in pharmaceutical raw materials and additives tailored for the animal feed industry. With a strategic focus on sourcing high-quality supplies, Kempex procures a substantial portion of its inventory from regions outside Europe, serving clientele primarily across Europe and the Middle East. Following an investment by MKB Fonds, Kempex embarked on a dynamic buy-and-build strategy aimed at enhancing its market presence and offerings. This strategic endeavor reached a significant milestone in September 2014 with the acquisition of the veterinary activities of Tocelo Pharma. Under the brand name Tocelo Vet, Kempex continued and expanded upon these activities, solidifying its position as a leading player in the veterinary pharmaceutical sector.

Important events

2014

Tocelo Vet

Producent van farmaceutische ingrediënten voor de veterinaire industrie